SEAL device registry for certain brain aneurysms treated through blood vessels
Part of Heart & circulation clinical trials.
This study follows people who have a brain aneurysm that can be treated using the SEAL device placed from inside a blood vessel. It aims to track how well the treatment works and how safely it can be used in real-world care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old when screened.
- You have an aneurysm (either unruptured needing treatment or a ruptured aneurysm) that doctors judge is suitable for the SEAL device.
- The aneurysm must be a sac-like (saccular) type, located at a branching spot or sidewall, and be 2.5 to 20 mm wide.
- For ruptured aneurysms: you must be neurologically stable, not needing an external brain drain (EVD) before enrollment, and have limited disability before the event.
- The treatment plan must not require other implanted devices ahead of time (except if needed for safety).
- You must be able to follow all study visits and have consent paperwork signed by you or a legal representative.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called the Surpass Elite with GUARDian Flow Diverter to treat a single, unruptured brain aneurysm. If you have a wide-neck aneurysm on the internal carotid artery or its branches, this study may help determine if the device is safe and effective for you.
This trial is testing a new stent (a small mesh tube) designed to treat wide-necked brain aneurysms. If you have this type of aneurysm, the stent helps hold coils in place to block blood flow and prevent rupture.
This trial tests a new device to block blood flow into unruptured brain aneurysms (balloon-like bulges). It is for adults whose aneurysm has not bled and fits specific size requirements. The goal is to see if the device is safe and works well.
This trial tests a new device, called LuSeed, for treating brain aneurysms that haven't burst. The device is placed inside the aneurysm to block blood flow and prevent rupture. The study aims to see if the device is safe and works well in patients with a specific type of aneurysm.
This trial studies an in-the-aneurysm device placed through a blood vessel to treat certain wide-neck brain aneurysms. It may help prevent aneurysm complications and reduce the risk of needing other procedures, but eligibility depends heavily on your aneurysm shape and health.
This trial tests a new device that is placed inside a brain aneurysm to block blood flow and prevent it from bursting. It may be an option for people with a single brain aneurysm that has not been treated yet.
Hear when a new Aneurysm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.